• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
U.S. Sleep Apnea Diagnostics and Therapeutics Markets Product Image

U.S. Sleep Apnea Diagnostics and Therapeutics Markets

  • ID: 359167
  • October 2001
  • Region: United States
  • Frost & Sullivan



Untapped Patient Population Key to Industry Growth

Sleep apnea is as common a disease as adult diabetes. However, limited public

knowledge of this disorder and treatment options have left the vast majority
of sufferers undiagnosed. Considering the potential patient population, the
possibility for growth within this underserved market is tremendous. As there
is no cure for obstructive sleep apnea (OSA), the dependence on

therapeutic equipment will result in strong product demand by a more
cognizant populace.

This Frost & Sullivan study analyzes the state of the U.S. sleep apnea markets,
including in-depth evaluations of the diagnostic and therapeutic sectors. By
monitoring consumer trends and providing expert forecasts, this research
offers a comprehensive guide to this flourishing field.

Reimbursement Policies Impact Therapeutics Sales

Favorable healthcare insurance reimbursements for nasal and facial interfaces
continue to drive replacement sales within the therapeutics market. In
addition to normal product deterioration, private and government healthcare

providers have positively influence sales READ MORE >

Note: Product cover images may vary from those shown

1. Executive Summary
A. Market Overview

1. Introduction
B. Market Engineering Awards

1. Entrepreneurial Award

2. Growth Strategy Award

3. Product Line Strategy Award

4. Market Engineering Leadership Award

2. Sleep Apnea Diagnostic Market
A. Market Forecasts

1. Overview

2. Revenue Forecasts

3. Unit Shipment Forecasts

4. Demand Analysis

5. Competitive Analysis

6. Market Engineering Analysis
B. Market Trends

1. Market Drivers

2. Market Restraints

3. Challenge and Strategic Recommenation

4. Technology Trends

5. Product Analysis
C. Full Polysomnography Segment

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
D. Partial Polysomnography

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
E. Portable Polysomnography

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
F. Other Diagnostic Devices

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends

3. Sleep Apnea Therapeutic Market
A. Market Forecasts

1. Overview

2. Revenue Forecasts

3. Unit Shipment Forecast

4. Demand Analysis

5 Competitive Analysis

6. Market Engineering Analysis
B. Market Trends

1. Market Drivers

2. Market Restraints

3. Technology Trends

4. Product Analysis
C. CPAP Segment

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
D. BiLevel CPAP

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
E. Auto CPAP

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends
F. Facial Interfaces

1. Revenue Forecasts

2. Unit Shipment Forecast

3. Market Trends

4. Special Section: Sleep Apnea Models
A. Models

1. OSA Prevalence Models

2. Diagnosis Rate Model

3. Saturation Model

List Of Figures

Chapter 2

Total Sleep Apnea Diagnostics Market: Market Segmentation (U.S.), 2000
Total Sleep Apnea Diagnostics Market: Revenue Forecasts (U.S.), 1997-2007
Total Sleep Apnea Diagnostics Market: Percent of Revenues by Product Type (U.S.), 1997-2007
Total Sleep Apnea Diagnostics Market: Unit Shipment Forecasts (U.S.), 1997-2007
Total Sleep Apnea Diagnostics Market: Company Market Share by Revenues (U.S.), 2000
Total Sleep Apnea Diagnostics Market: Competitive Structure (U.S.), 2000
Total Sleep Apnea Diagnostics Market: Market Drivers Ranked in Order of Impact (U.S.), 2000-2007
Total Sleep Apnea Diagnostics Market: Market Restraints Ranked in Order of Impact (U.S.), 2000-2007
Total Sleep Apnea Diagnostics Market: Products Offered by Major Market Participants (U.S.), 2000
Fixed Polysomnography Market: Revenue Forecasts (U.S.), 1997-2007
Fixed Polysomnography Market: Unit Shipment Forecasts (U.S.), 1997-2007
Portable Polysomnography Market: Revenue Forecasts (U.S.), 1997-2007
Portable Polysomnography Market: Unit Shipment Forecasts (U.S.), 1997-2007
Ambulatory Polysomnography Market: Revenue Forecasts (U.S.), 1997-2007
Ambulatory Polysomnography Market: Unit Shipment Forecasts (U.S.), 1997-2007
Partial Channel Devices Market: Revenue Forecasts (U.S.), 1997-2007
Partial Channel Devices Market: Unit Shipment Forecasts (U.S.), 1997-2007

Chapter 3

Total Sleep Apnea Therapeutics Market: Revenue Forecasts (U.S), 1997-2007
Total Sleep Apnea Therapeutics Market: Percent of Revenues by Product Type (U.S.), 1997-2007
Total Sleep Therapeutics Market: Unit Shipment Forecasts (U.S.), 1997-2007
Total Sleep Therapeutics Market: Competitive Structure (U.S.), 2000
Total Sleep Apnea Therapeutics Market: Company Market Share by Revenues (U.S.), 2000
Total Sleep Apnea Therapeutics Market: Market Drivers Ranked in Order of Impact (U.S.), 2000-2007
Total Sleep Apnea Therapeutics Market: Market Restraints Ranked in Order of Impact (U.S.), 2000-2007
Total Sleep Therapeutics Market: Products Offered by Major Market Participants (U.S.), 2000
CPAP Market: Revenue Forecasts (U.S.), 1997-2007
CPAP Market: Unit Shipment Forecasts (U.S.), 1997-2007
Bilevel CPAP Market: Revenue Forecasts (U.S.), 1997-2007
Bilevel CPAP Market: Unit Shipment Forecasts (U.S.), 1997-2007
Auto CPAP Market: Revenue Forecasts (U.S.), 1997-2007
Auto CPAP Market: Unit Shipment Forecasts (U.S.), 1997-2007
Facial Interfaces Market: Revenue Forecasts (U.S.), 1997-2007
Facial Interfaces Market: Unit Shipment Forecasts (U.S.), 1997-2007

Chapter 4

OSA Prevalence Model A - Calculation, 2000
OSA Prevalence Model: Model A - 9 % General Prevalence (U.S.), 2000-2010
OSA Prevalence Model: Model B - 4% General Male Prevalence, 2% General Female Prevalence (U.S.), 2000-2010
OSA Prevalence Model: Model C - 4% Adult Male Prevalence, 2% Adult Female Prevalence (U.S.), 2000-2010
Diagnosis Rate Model : Sleep Center Model (Model 1) - 2000
Diagnosis Rate Model: Medicare Therapeutics Model (Model 2)- Calculation and Values, 2000
Diagnosis Rate Model: Medicare Diagnosis Model (Model 3)- Calculation and Values, 2000
Market Saturation Model , Model 1: 9 % General Prevalence - 2000 - 2010

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos